Patient Note — 138311
progress_notes_138311_1_deid.txt
Demographics & Encounter
Patient ID138311 (PHI redacted)
Age / Gender56 / Male
Date of Service2026-04-14
ProviderNone
FacilityPOTOMAC UROLOGY CENTER - National Harbor
PayerHighmark Medicare
Reason1. 2 WK F/U
Diagnoses
C61
Prostate cancer
R97.20
Elevated prostate specific antigen [PSA]
S06.890A
Other specified intracranial injury without loss of consciousness, initial encounter
Medications
Fluticasone Furoate
Rosuvastatin Calcium , Notes to Pharmacist:
Abilify , Notes to Pharmacist:
DULoxetine HCl , Notes to Pharmacist:
dilTIAZem HCl , Notes to Pharmacist:
Cefuroxime Axetil
Discontinued
levoFLOXacin
Progress Note: [PROVIDER_NAME], MD 04/14/2026
Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com)
Generated for Printing/Faxing/eTransmitting on: 04/15/2026 02:30 PM EDT
1/4
4/15/26, 11:30 AM Print Preview
[PATIENT_NAME] DOB: [DOB] (56 yo M) Acc No. [ACCOUNT_ID] DOS: 04/14/2026
Medication List reviewed and reconciled with the patient
Past Medical History
- Brain injury
- Ptsd
- Pre diabetic
- High liver enzymes
- Depression
Vitals
RR
16.0
HR
73.0
BP
101/74
BMI
24.39
WEIGHT
170 lbs
HEIGHT_IN
70.0
Clinical Summary (HPI)
Elevated PSA/Screening: 56yM with elevated PSA presents for biopsy review History: Flow is good. Nocturia 1-2. No dysuria or gross hematuria. No prostate meds. History of TBI secondary to fall 2020. --------------- The patient's previous work-up history is listed below: PSA: 5.8 (Nov 2025) Prostate MRI (Feb 2026): Prostate measures 3.7 x 2.6 x 4.8 cm with a calculated volume of 24 cc. PI-RADS 4 left peripheral zone lesion. No evidence for extracapsular extension. (Independently reviewed the actual images/tracings and came to my own conclusions) FamHx: negative for prostate cancer. Prostate Cancer (localized): Prostate Bx information Date of biopsy 03-2026 Fusion biopsy? Yes Gleason Score (all positives) 3+4=7 (Grade Group 2) Total cores positive (not including fusion) #1: Gleason 3+4=7, #2: Gleason 3+4=7, #4: Gleason 3+4=7 Largest % core involvement 60
Raw Note (de-identified preview)
4/15/26, 11:30 AM Print Preview
[PATIENT_NAME] DOB: [DOB] (56 yo M) Acc No. [ACCOUNT_ID] DOS: 04/14/2026
[PATIENT_NAME]
56 Y old Male, DOB: [DOB]
Account: [ACCOUNT_ID]: [PHONE] [ADDRESS]
Home: [PHONE]
Guarantor: [GUARANTOR_NAME] Insurance: Highmark Medicare
PCP: [PROVIDER_NAME] Referring: [PROVIDER_NAME]
Appointment Facility: POTOMAC UROLOGY CENTER - National Harbor
04/14/2026 Prostate bx fu: [PROVIDER_NAME], MD
Reason for Appointment
1. 2 WK F/U
History of Present Illness
Elevated PSA/Screening:
56yM with elevated PSA presents for biopsy review
History:
Flow is good. Nocturia 1-2. No dysuria or gross hematuria. No prostate meds.
History of TBI secondary to fall 2020.
---------------
The patient's previous work-up history is listed below:
PSA: 5.8 (Nov 2025)
Prostate MRI (Feb 2026): Prostate measures 3.7 x 2.6 x 4.8 cm with a calculated volume of 24 cc. PI-RADS 4 left peripheral
zone lesion. No evidence for extracapsular extension.
(Independently reviewed the actual images/tracings and came to my own conclusions)
FamHx: negative for prostate cancer.
Prostate Cancer (localized):
Prostate Bx information
Date of biopsy 03-2026
Fusion biopsy? Yes
Gleason Score (all positives) 3+4=7 (Grade Group 2)
Total cores positive (not including fusion) #1: Gleason 3+4=7, #2: Gleason 3+4=7, #4: Gleason 3+4=7
Largest % core involvement 60
Current Medications
Taking
Fluticasone Furoate
Rosuvastatin Calcium , Notes to Pharmacist: 20mg
Abilify , Notes to Pharmacist: 2mg
DULoxetine HCl , Notes to Pharmacist: 20mg
dilTIAZem HCl , Notes to Pharmacist: 120mg
Cefuroxime Axetil 500 MG Tablet TAKE 1 TABLET (500 MG) BY MOUTH TWICE A DAY FOR 14 DAYS Oral
Discontinued
levoFLOXacin 500 MG Tablet 1 tablet Orally one time, take the morning of your biopsy procedure
Progress Note: [PROVIDER_NAME], MD 04/14/2026
Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com)
Generated for Printing/Faxing/eTransmitting on: 04/15/2026 02:30 PM EDT
1/4
4/15/26, 11:30 AM Print Preview
[PATIENT_NAME] DOB: [DOB] (56 yo M) Acc No. [ACCOUNT_ID] DOS: 04/14/2026
levoFLOXacin 500 MG Tablet 1 tablet Orally one time, take the morning of your biopsy procedure
levoFLOXacin 500 MG Tablet 1 tablet Orally one time, take the morning of your biopsy procedure
levoFLOXacin 500 MG Tablet 1 tablet Orally one time, take the morning of your biopsy procedure
Medication List reviewed and reconciled with the patient
Past Medical History
Brain injury.
Ptsd.
Pre diabetic.
High liver enzymes.
Depression.
Surgical History
craniectomy, cranial plasty 5 yrs ago
colonoscsopy 2yrs ago
Family History
Father: deceased, liver problems, possible colon or prostate cancer (unsure)
Mother: deceased, heart attack
Social History
Smoking: no
Recreational drug use: no.
Exercise: yes.
Caffeine: no.
Sexually active: yes.
Tobacco Control (Standard)
Tobacco use: Nonsmoker
Screening
Allergies
Amoxicillin
Hospitalization/Major Diagnostic Procedure
inova/infection,acute prostatis 4/1-4/2026
Review of Systems
11 system Review